Pancreatic cancer presents one of the most challenging battles in modern oncology, but understanding treatment options—both standard and investigational—empowers patients and their families to navigate this difficult journey with greater confidence and hope.

Understanding Treatment Goals in Pancreatic Cancer Care

When someone receives a diagnosis of pancreatic cancer, the path forward depends on many individual factors. Treatment aims vary based on where the cancer is located in the pancreas, how far it has spread, and the person’s overall health condition. For some patients, the goal is to remove the tumor completely through surgery, offering the possibility of long-term survival. For others, treatment focuses on controlling symptoms, slowing the disease’s progression, and maintaining the best possible quality of life for as long as possible.^[6]

The reality of pancreatic cancer is sobering—it often goes undetected until it has reached an advanced stage because early symptoms are either absent or easily mistaken for other common conditions. This delayed detection means that only about 20% of patients have cancer that can be surgically removed at the time of diagnosis.^[4] Even when surgery is possible, the disease has a tendency to return, which is why comprehensive treatment often involves multiple approaches working together.

Medical teams have established standard treatments that have been studied extensively and approved by healthcare authorities worldwide. At the same time, researchers are constantly exploring new therapies through clinical trials—carefully monitored research studies that test whether new treatments are safe and effective. These trials represent hope for better outcomes and are an important option for many patients to consider. The disease requires a team approach, bringing together surgeons, medical oncologists who specialize in drug treatments, radiation oncologists, and other specialists who collaborate to create the best treatment plan for each individual.^[4]

Standard Treatment Approaches

Surgery: The Foundation of Curative Treatment

Surgery remains the only treatment with the potential to cure pancreatic cancer, but it is only suitable for patients whose tumors have not spread beyond the pancreas and do not involve major blood vessels in ways that make removal impossible.^[6] The type of surgical procedure depends on where the tumor is located within the pancreas.

For cancers in the head of the pancreas, surgeons perform a complex operation called a pancreaticoduodenectomy, more commonly known as the Whipple procedure. This surgery removes the head of the pancreas, part of the small intestine, the gallbladder, part of the bile duct, and sometimes a portion of the stomach. The remaining organs are then reconnected to allow digestion to continue. This is major surgery that typically requires several weeks of recovery.^[10]

When the tumor is in the body or tail of the pancreas, a distal pancreatectomy is performed, removing the body and tail of the pancreas and often the spleen as well. In some cases, when the entire pancreas is affected or there are multiple tumors, surgeons may need to perform a total pancreatectomy, removing the entire pancreas. This leads to diabetes because the pancreas normally produces insulin, and patients will need lifelong insulin therapy and digestive enzyme supplements.^[16]

Surgery carries risks, as do all major operations. Complications can include infection, bleeding, delayed stomach emptying, and problems with the surgical connections that were created. Choosing a hospital that performs many pancreatic surgeries each year is important because surgical teams with more experience tend to have better outcomes and fewer complications.

Chemotherapy: Medication to Fight Cancer Cells

Chemotherapy involves using medications that kill rapidly dividing cancer cells or stop them from multiplying. These drugs travel throughout the body in the bloodstream, which makes them useful for reaching cancer cells that may have spread beyond the pancreas, even if that spread is not yet visible on scans.^[15]

Chemotherapy plays several roles in pancreatic cancer treatment. It may be given before surgery, called neoadjuvant therapy, to shrink tumors and make them easier to remove. It is commonly given after surgery, known as adjuvant therapy, to kill any remaining cancer cells and reduce the risk of the cancer coming back. For patients whose cancer cannot be removed with surgery, chemotherapy is a primary treatment to slow the disease’s progression and control symptoms.^[12]

Several chemotherapy drugs are used for pancreatic cancer. Gemcitabine has been a standard treatment for many years. It is often combined with other drugs for better effectiveness. One common combination is FOLFIRINOX, which includes four different drugs: fluorouracil (also called 5-FU), leucovorin, irinotecan, and oxaliplatin. This combination can be quite effective but also causes more side effects, so it is typically reserved for patients who are in good overall health.^[12]

Another combination pairs gemcitabine with a drug called nab-paclitaxel, which is a form of the chemotherapy drug paclitaxel attached to tiny protein particles. This combination has shown good results in extending survival for patients with advanced pancreatic cancer.^[12]

The duration of chemotherapy treatment varies widely. Adjuvant chemotherapy after surgery is typically given for about six months. For patients with advanced disease, treatment may continue for as long as it is working and the side effects remain manageable, sometimes many months or even years.

Chemotherapy side effects occur because these drugs also affect some normal cells that divide rapidly, such as those in the hair follicles, digestive tract, and bone marrow. Common side effects include fatigue, nausea and vomiting, diarrhea, mouth sores, hair loss, and an increased risk of infection due to low white blood cell counts. Peripheral neuropathy—tingling, numbness, or pain in the hands and feet—is particularly associated with drugs like oxaliplatin and paclitaxel. Many side effects can be managed with additional medications or adjustments to the chemotherapy doses, and most improve after treatment ends.^[15]

Radiation Therapy: Using Energy to Target Cancer

Radiation therapy uses high-energy x-rays or other types of radiation to kill cancer cells or prevent them from growing. For pancreatic cancer, radiation is usually delivered from a machine outside the body, called external beam radiation therapy. The treatment itself is painless and takes only a few minutes each day, though patients typically need to come for treatment five days a week for several weeks.^[15]

Radiation is often combined with chemotherapy, a combination called chemoradiation or chemoradiotherapy. The chemotherapy makes the cancer cells more sensitive to radiation, improving the treatment’s effectiveness. This approach may be used before surgery to shrink tumors or after surgery to kill any remaining cancer cells in the area where the tumor was removed.

For patients with locally advanced pancreatic cancer that cannot be surgically removed but has not spread to distant organs, chemoradiation may be used to control the tumor’s growth and relieve symptoms. This can sometimes shrink the tumor enough that surgery becomes possible, though this does not happen for all patients.^[15]

Radiation therapy side effects depend on the area being treated. For pancreatic cancer, common side effects include fatigue, nausea, diarrhea, and skin changes in the treatment area that resemble a sunburn. These effects typically develop gradually during treatment and improve within a few weeks after treatment ends. Long-term effects can include digestive problems if the intestines were in the radiation field.

Targeted Therapy and Immunotherapy

Beyond traditional chemotherapy, some patients may benefit from newer types of drug treatments. Targeted therapy drugs work differently than chemotherapy—they target specific molecules or pathways that cancer cells need to grow and survive, potentially causing less harm to normal cells.

One targeted therapy used in pancreatic cancer is erlotinib, which blocks a protein on cancer cells called EGFR that helps them grow. Erlotinib is sometimes combined with gemcitabine for patients with advanced pancreatic cancer, though the benefit is modest and it causes additional side effects including skin rashes.^[15]

For patients whose tumors have certain inherited genetic changes in genes called BRCA1 or BRCA2, drugs called PARP inhibitors may be helpful. These include medications like olaparib. PARP inhibitors work by blocking a protein that helps repair DNA in cells, which particularly affects cancer cells with BRCA mutations because they already have difficulty repairing DNA. This can cause the cancer cells to die. Not all patients with BRCA mutations will respond to these drugs, but for some they can help control the cancer for a period of time.^[15]

Immunotherapy is a treatment approach that helps the body’s own immune system recognize and attack cancer cells. For pancreatic cancer, immunotherapy is currently only recommended for the small number of patients whose tumors have a specific genetic feature called high microsatellite instability (MSI-H) or mismatch repair deficiency (dMMR). Drugs like pembrolizumab, which is a type of immunotherapy called a checkpoint inhibitor, can be effective for these patients. However, only about 1-2% of pancreatic cancers have these features, so routine genetic testing of the tumor is necessary to identify who might benefit.^[15]

Promising Treatments Being Tested in Clinical Trials

Because standard treatments for pancreatic cancer have significant limitations, researchers worldwide are intensively studying new approaches. Clinical trials offer patients access to cutting-edge therapies that are not yet available as standard treatment. Participation in a clinical trial also contributes to medical knowledge that may help future patients.

Understanding Clinical Trial Phases

Clinical trials happen in stages, each with a different purpose. Phase I trials are the first step, involving a small number of patients to test whether a new treatment is safe, determine appropriate doses, and identify side effects. Phase II trials involve more patients and focus on whether the treatment works against the cancer while continuing to monitor safety. Phase III trials are large studies that compare the new treatment to the current standard treatment to see if the new approach is better, equally effective, or causes fewer side effects. Only treatments that successfully complete these phases and show clear benefits can be approved by regulatory authorities for general use.^[6]

Novel Drug Combinations and Improved Chemotherapy

Researchers are testing numerous combinations of existing and new chemotherapy drugs to find regimens that are more effective or cause fewer side effects. Some trials are investigating whether adding new drugs to standard combinations like FOLFIRINOX or gemcitabine plus nab-paclitaxel can improve outcomes. These studies are being conducted in various settings—before surgery, after surgery, and for advanced disease.

Other trials are exploring ways to deliver chemotherapy more effectively to the tumor. This includes testing different schedules, doses, and routes of administration that might allow the drugs to reach cancer cells better while reducing harm to normal tissues.

Immunotherapy Approaches

While current immunotherapy works for only a small fraction of pancreatic cancer patients, researchers are actively trying to expand its usefulness. Most pancreatic cancers have features that help them hide from the immune system or actively suppress immune responses. Scientists are testing various strategies to overcome this.

Some trials are combining different types of immunotherapy drugs together, or pairing immunotherapy with chemotherapy or radiation, hoping that these combinations will make the immune system more effective against pancreatic cancer. Other studies are investigating cancer vaccines—treatments that train the immune system to recognize specific proteins found on pancreatic cancer cells. These vaccines are different from preventive vaccines; they are designed to treat existing cancer rather than prevent disease from developing.

Another experimental approach involves collecting a patient’s own immune cells, modifying them in the laboratory to better recognize cancer cells, and then returning them to the patient’s body. This type of treatment, called adoptive cell therapy or CAR T-cell therapy, has shown remarkable results in some blood cancers and is now being tested for solid tumors including pancreatic cancer, though it is still in early research stages for this disease.

Targeted Therapies Against Specific Mutations

About 90% of pancreatic cancers have mutations in a gene called KRAS, which causes cells to grow and divide uncontrollably. For decades, this protein was considered “undruggable,” but scientists have recently made breakthroughs. New drugs that specifically target the most common KRAS mutation, called KRAS G12C, have been developed. However, this particular mutation is found in only a small percentage of pancreatic cancers. Researchers are now working on drugs that target other KRAS mutations that are more common in pancreatic cancer, and several of these are in clinical trials.^[17]

Other targeted therapies in development aim at different molecular pathways that pancreatic cancer cells depend on for survival and growth. These include drugs targeting proteins involved in cell signaling, metabolism, and the tumor microenvironment—the surrounding tissue and blood vessels that support tumor growth.

Therapies Targeting the Tumor Environment

Pancreatic cancers are surrounded by dense fibrous tissue called stroma, which acts as a barrier that prevents chemotherapy drugs and immune cells from reaching the cancer cells effectively. Some clinical trials are testing drugs designed to break down this stromal barrier, making tumors more vulnerable to other treatments. These drugs might work by blocking certain enzymes or signaling molecules that maintain the stroma.

Pancreatic tumors also need blood vessels to supply them with nutrients and oxygen. Anti-angiogenic drugs work by blocking the formation of new blood vessels, essentially starving the tumor. While these drugs have shown benefits in other cancer types, results in pancreatic cancer have been mixed, and research continues to determine the best way to use them, possibly in combination with other treatments.

Where Clinical Trials Are Available

Clinical trials for pancreatic cancer are being conducted at major cancer centers throughout the United States, Europe, and other parts of the world. Eligibility for trials depends on many factors including the stage of cancer, previous treatments received, overall health status, and specific characteristics of the tumor. Patients interested in clinical trials should discuss this option with their oncology team, who can help identify appropriate studies and facilitate enrollment.^[6]

Most Common Treatment Methods

• Surgery
  • Pancreaticoduodenectomy (Whipple procedure) for tumors in the head of the pancreas, removing the head of the pancreas, part of the small intestine, gallbladder, and sometimes part of the stomach
  • Distal pancreatectomy for tumors in the body or tail of the pancreas, removing these sections and often the spleen
  • Total pancreatectomy in cases requiring removal of the entire pancreas, necessitating lifelong insulin and enzyme supplementation
• Chemotherapy
  • Gemcitabine as a standard single agent or in combinations with other drugs
  • FOLFIRINOX regimen combining fluorouracil, leucovorin, irinotecan, and oxaliplatin for patients in good overall health
  • Gemcitabine plus nab-paclitaxel combination for advanced disease
  • Neoadjuvant chemotherapy given before surgery to shrink tumors
  • Adjuvant chemotherapy administered after surgery, typically for about six months, to reduce recurrence risk
• Radiation Therapy
  • External beam radiation therapy delivered daily over several weeks
  • Chemoradiation combining radiation with chemotherapy drugs to enhance effectiveness
  • Used before surgery to shrink tumors or after surgery to eliminate remaining cancer cells
  • Applied to control locally advanced disease that cannot be surgically removed
• Targeted Therapy
  • Erlotinib targeting EGFR protein, sometimes combined with gemcitabine
  • PARP inhibitors like olaparib for patients with BRCA1 or BRCA2 mutations
  • Investigational drugs targeting KRAS mutations and other molecular pathways in clinical trials
• Immunotherapy
  • Checkpoint inhibitors like pembrolizumab for tumors with microsatellite instability or mismatch repair deficiency
  • Experimental combination immunotherapies being tested to overcome immune suppression
  • Cancer vaccines designed to train the immune system to recognize pancreatic cancer cells
  • Adoptive cell therapy approaches in early-stage research
• Supportive and Palliative Treatments
  • Procedures to relieve bile duct blockage and jaundice using stents placed during endoscopy
  • Pain management with medications and sometimes nerve blocks
  • Enzyme supplements to aid digestion when pancreatic function is impaired
  • Nutritional support to address weight loss and maintain strength

Managing Treatment Side Effects and Maintaining Quality of Life

Living with pancreatic cancer and its treatments requires attention to many aspects of daily life beyond the cancer itself. The disease and its treatments can cause symptoms that affect eating, energy levels, and overall comfort, but there are ways to manage these challenges.

Digestive problems are common because the pancreas normally produces enzymes that help digest food, particularly fats. When the pancreas is affected by cancer or has been partially or completely removed, patients may experience diarrhea, bloating, or greasy stools. Taking pancreatic enzyme supplements with meals and snacks can significantly improve digestion and nutrient absorption. These supplements contain the enzymes that the pancreas would normally produce.^[2]

Maintaining adequate nutrition is crucial but often challenging because pancreatic cancer and chemotherapy frequently cause loss of appetite, nausea, and changes in taste. Eating small, frequent meals rather than three large meals may be easier. Focusing on foods that are appealing and easy to digest, and working with a dietitian who specializes in cancer care, can help ensure adequate calorie and protein intake to maintain strength.^[15]

Pain management is an important part of pancreatic cancer care. Pain may come from the tumor itself, from surgery, or from cancer that has spread. A range of pain medications is available, from over-the-counter options to prescription opioids for more severe pain. Some patients benefit from procedures that block the nerves carrying pain signals from the pancreas area. It is important to communicate openly with healthcare providers about pain so it can be adequately controlled.

Fatigue is nearly universal among cancer patients, caused by the cancer itself, treatments, poor nutrition, pain, and emotional stress. While rest is important, gentle physical activity when feeling up to it can actually help maintain energy levels and improve mood. Even short walks can be beneficial.

Emotional and psychological support is just as important as physical care. A cancer diagnosis brings fear, anxiety, sadness, and many other difficult emotions. These feelings are normal and valid. Speaking with counselors, psychologists, or psychiatrists who specialize in working with cancer patients can provide coping strategies. Some patients find comfort in meditation, relaxation techniques, or spiritual practices. Family and friends provide crucial support, though they too may be struggling with the situation.